Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine

Keyphrases

• Pancreas Allograft 100%
• Cyclosporine 100%
• Sirolimus 100%
• Graft Survival 100%
• Immune Regulation 100%
• Thymoglobulin 100%
• HLA Antibodies 100%
• Suppressor Cells 100%
• Pancreas 66%
• Kidney 66%
• Immunomodulatory 66%
• Donor-specific 66%
• Flow Cytometry 33%
• Clinical Outcomes 33%
• Immune Response 33%
• Immunosuppression 33%
• Acute Rejection 33%
• Transplant Recipients 33%
• Kidney Transplant Recipients 33%
• Sepsis 33%
• Graft Function 33%
• Corticosteroids 33%
• Cell Function 33%
• Antibody Response 33%
• Graft Loss 33%
• Pancreas Transplant 33%
• Pancreas Graft 33%
• Acute Rejection Episode 33%
• Clinical Consequences 33%
• CD4 Count 33%
• Non-donors 33%
• No Adverse Effect 33%
• Cell-based Assay 33%
• T Cell Subsets 33%
• Reduced Dose 33%
• Immune Monitoring 33%
• Specific Flow 33%
• Cell Activity 33%
• Specific Immunity 33%
• Monitoring Study 33%
• Induction Protocol 33%
• CD8 Count 33%
• Cross-matching 33%

Immunology and Microbiology

• Allograft 100%
• Ciclosporin 100%
• Sirolimus 100%
• Pancreas 100%
• Immunoregulation 100%
• Anti-Thymocyte Globulin 100%
• HLA Antibody 100%
• Suppressor Cell 100%
• Pancreas Transplantation 66%
• Acute Graft Rejection 66%
• Cell Function 33%
• Immune Response 33%
• Immunosuppression 33%
• Antibody Response 33%
• CD3 Antigen 33%
• Adaptive Immune System 33%
• Cell Activity 33%
• T Cell Subset 33%
• CD4 Lymphocyte Count 33%
• Cell Assay 33%
• CD8 Lymphocyte Count 33%